Cargando…
Clinical trials in pulmonary hypertension: Time for a consortium
Current and past clinical trials in pulmonary hypertension, while valuable, are limited by the absence of mechanistic aims, by dissatisfaction with endpoints and the inability to share data. Clinical studies in pulmonary hypertension might be enhanced by a consortium approach that utilizes the exper...
Autores principales: | Newman, John H., Elliott, Gregory C., Haworth, Glennis S., Zampaglione, Edio, Brar, Satjit, Gibbs, Simon J., Sandoval, Julio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641735/ https://www.ncbi.nlm.nih.gov/pubmed/23662202 http://dx.doi.org/10.4103/2045-8932.109922 |
Ejemplares similares
-
The pulmonary hypertension academic research consortium
por: Rich, Stuart
Publicado: (2013) -
Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committee
por: Adatia, Ian, et al.
Publicado: (2013) -
Advancing clinical trial design in pulmonary hypertension
por: Grieve, Andy P., et al.
Publicado: (2013) -
Pulmonary Hypertension in Heart Failure Patients
por: Rao, Sriram D, et al.
Publicado: (2020) -
The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension
por: Wronski, Samantha L., et al.
Publicado: (2019)